Literature DB >> 2564565

Diagnostic value of ascites adenosine deaminase in tuberculous peritonitis.

M D Voigt1, I Kalvaria, C Trey, P Berman, C Lombard, R E Kirsch.   

Abstract

The value of ascitic fluid adenosine deaminase activity in distinguishing tuberculosis from other causes of ascites was examined in a retrospective study of 41 patients with bacteriologically confirmed tuberculous peritonitis and 41 control patients, matched for age and sex, with ascites of other causes (12 alcoholic cirrhosis, 5 cryptogenic cirrhosis, 12 malignant disorders, 3 pancreatitis, and 9 miscellaneous causes). The mean ascites adenosine deaminase activity was 99.8 (SD 49.1) in tuberculous patients and 14.8 (8.4) U/l in control patients (p less than 0.0001). A cutoff of 32.3 U/l had a sensitivity of 95% and specificity of 98% in distinguishing between the two groups. In a subsequent prospective study of 64 patients with ascites, 11 were found to have tuberculosis. Of the others, 23 had cirrhosis (18 alcoholic, 5 cryptogenic), 17 malignant disorders, 3 pancreatitis, 5 cor pulmonale, 3 congestive cardiac failure, 1 systemic mastocytosis, and 1 renal failure and hypothyroidism. The mean ascites adenosine deaminase activity was 112.6 (45.0) U/l in the patients with tuberculous ascites and 16.3 (36.7) U/l (p less than 0.0001) in those with ascites of other causes. In this study, adenosine deaminase had a sensitivity of 100% and specificity of 96% in discriminating tuberculosis from other causes of ascites. These findings suggest that the ascitic fluid adenosine deaminase activity may be used to identify patients in whom the diagnosis of abdominal tuberculosis must be pursued.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2564565     DOI: 10.1016/s0140-6736(89)92574-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  11 in total

1.  Peritoneal tuberculosis.

Authors:  T H Lingenfelser; I N Marks
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

2.  Tuberculous enteritis.

Authors:  F B Ahmed
Journal:  BMJ       Date:  1996-07-27

3.  The comparison of adenosine deaminase activity values with polymerase chain reaction results in patients with tuberculosis.

Authors:  O Canbolat; S Ulusdoyuran; G Ozgen; I Ceyhan; F Gümüşlü; A Akbay
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

Review 4.  Diagnosis of abdominal tuberculosis: experience from 11 cases and review of the literature.

Authors:  Ali Uzunkoy; Muge Harma; Mehmet Harma
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

5.  Adenosine deaminase activity in tuberculous peritonitis among patients with underlying liver cirrhosis.

Authors:  Yi-Jun Liao; Chun-Ying Wu; Shou-Wu Lee; Chia-Ling Lee; Sheng-Shun Yang; Chi-Sen Chang; Teng-Yu Lee
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

6.  Ascitic fluid gamma interferon concentrations and adenosine deaminase activity in tuberculous peritonitis.

Authors:  M A Sathar; A E Simjee; Y M Coovadia; P N Soni; S A Moola; B Insam; F Makumbi
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

7.  A 33-year-old Haitian immigrant with 7 months of abdominal pain and progressive distension.

Authors:  Shelli Farhadian; Sheela V Shenoi; Merceditas S Villanueva
Journal:  BMJ Case Rep       Date:  2014-07-09

Review 8.  KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2018-07-09

9.  Tuberculous abdominal cocoon mimicking peritoneal carcinomatosis.

Authors:  Zhi-Xin Meng; Yan Liu; Rui Wu; Kai Shi; Tao Li
Journal:  Antimicrob Resist Infect Control       Date:  2019-06-19       Impact factor: 4.887

Review 10.  Diagnostic accuracy of adenosine deaminase for tuberculous peritonitis: a meta-analysis.

Authors:  Yong-Chun Shen; Tao Wang; Lei Chen; Ting Yang; Chun Wan; Qian-Jing Hu; Fu-Qiang Wen
Journal:  Arch Med Sci       Date:  2013-08-08       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.